Cargando…

Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018

BACKGROUND: The National Colorectal Cancer Roundtable, a national coalition of public, private, and voluntary organizations, has recently announced an initiative to increase colorectal cancer (CRC) screening rates in the United States to 80% by 2018. The authors evaluated the potential public health...

Descripción completa

Detalles Bibliográficos
Autores principales: Meester, Reinier G S, Doubeni, Chyke A, Zauber, Ann G, Goede, S Luuk, Levin, Theodore R, Corley, Douglas A, Jemal, Ahmedin, Lansdorp-Vogelaar, Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567966/
https://www.ncbi.nlm.nih.gov/pubmed/25763558
http://dx.doi.org/10.1002/cncr.29336
_version_ 1782389863926988800
author Meester, Reinier G S
Doubeni, Chyke A
Zauber, Ann G
Goede, S Luuk
Levin, Theodore R
Corley, Douglas A
Jemal, Ahmedin
Lansdorp-Vogelaar, Iris
author_facet Meester, Reinier G S
Doubeni, Chyke A
Zauber, Ann G
Goede, S Luuk
Levin, Theodore R
Corley, Douglas A
Jemal, Ahmedin
Lansdorp-Vogelaar, Iris
author_sort Meester, Reinier G S
collection PubMed
description BACKGROUND: The National Colorectal Cancer Roundtable, a national coalition of public, private, and voluntary organizations, has recently announced an initiative to increase colorectal cancer (CRC) screening rates in the United States to 80% by 2018. The authors evaluated the potential public health benefits of achieving this goal. METHODS: The authors simulated the 1980 through 2030 United States population of individuals aged 50 to 100 years using microsimulation modeling. Test-specific historical screening rates were based on National Health Interview Survey data for 1987 through 2013. The effects of increasing screening rates from approximately 58% in 2013 to 80% in 2018 were compared to a scenario in which the screening rate remained approximately constant. The outcomes were cancer incidence and mortality rates and numbers of CRC cases and deaths during short-term follow-up (2013-2020) and extended follow-up (2013-2030). RESULTS: Increasing CRC screening rates to 80% by 2018 would reduce CRC incidence rates by 17% and mortality rates by 19% during short-term follow-up and by 22% and 33%, respectively, during extended follow-up. These reductions would amount to a total of 277,000 averted new cancers and 203,000 averted CRC deaths from 2013 through 2030. CONCLUSIONS: Achieving the goal of increasing the uptake of CRC screening in the United States to 80% by 2018 may have a considerable public health impact by averting approximately 280,000 new cancer cases and 200,000 cancer deaths within <20 years. Cancer 2015;121:2281–2285. © 2015 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
format Online
Article
Text
id pubmed-4567966
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-45679662015-11-27 Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018 Meester, Reinier G S Doubeni, Chyke A Zauber, Ann G Goede, S Luuk Levin, Theodore R Corley, Douglas A Jemal, Ahmedin Lansdorp-Vogelaar, Iris Cancer Communication BACKGROUND: The National Colorectal Cancer Roundtable, a national coalition of public, private, and voluntary organizations, has recently announced an initiative to increase colorectal cancer (CRC) screening rates in the United States to 80% by 2018. The authors evaluated the potential public health benefits of achieving this goal. METHODS: The authors simulated the 1980 through 2030 United States population of individuals aged 50 to 100 years using microsimulation modeling. Test-specific historical screening rates were based on National Health Interview Survey data for 1987 through 2013. The effects of increasing screening rates from approximately 58% in 2013 to 80% in 2018 were compared to a scenario in which the screening rate remained approximately constant. The outcomes were cancer incidence and mortality rates and numbers of CRC cases and deaths during short-term follow-up (2013-2020) and extended follow-up (2013-2030). RESULTS: Increasing CRC screening rates to 80% by 2018 would reduce CRC incidence rates by 17% and mortality rates by 19% during short-term follow-up and by 22% and 33%, respectively, during extended follow-up. These reductions would amount to a total of 277,000 averted new cancers and 203,000 averted CRC deaths from 2013 through 2030. CONCLUSIONS: Achieving the goal of increasing the uptake of CRC screening in the United States to 80% by 2018 may have a considerable public health impact by averting approximately 280,000 new cancer cases and 200,000 cancer deaths within <20 years. Cancer 2015;121:2281–2285. © 2015 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Blackwell Publishing Ltd 2015-07-01 2015-03-12 /pmc/articles/PMC4567966/ /pubmed/25763558 http://dx.doi.org/10.1002/cncr.29336 Text en © 2015 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Communication
Meester, Reinier G S
Doubeni, Chyke A
Zauber, Ann G
Goede, S Luuk
Levin, Theodore R
Corley, Douglas A
Jemal, Ahmedin
Lansdorp-Vogelaar, Iris
Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018
title Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018
title_full Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018
title_fullStr Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018
title_full_unstemmed Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018
title_short Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018
title_sort public health impact of achieving 80% colorectal cancer screening rates in the united states by 2018
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567966/
https://www.ncbi.nlm.nih.gov/pubmed/25763558
http://dx.doi.org/10.1002/cncr.29336
work_keys_str_mv AT meesterreiniergs publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018
AT doubenichykea publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018
AT zauberanng publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018
AT goedesluuk publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018
AT levintheodorer publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018
AT corleydouglasa publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018
AT jemalahmedin publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018
AT lansdorpvogelaariris publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018